On this edition of Your Call, we discuss the #3not30 campaign, a Women's Health Access Matters (WHAM) initiative to increase investment in sex-based research.
WHAM is launching this campaign in recognition of the 30th anniversary of the NIH Revitalization Act, a law mandating that women and minorities be included in all clinical trials and research funded by the NIH.
Today, cardiovascular disease is the number one killer of women in the US, yet only one-third of participants in clinical trials are female, according to WHAM. Women are two-thirds of the 5.7 million people suffering from Alzheimer's disease, yet 66 percent of the animals used in Alzheimer's research are male or of unreported gender.
Investing $350 million in women's health research is estimated to generate $14 billion for the economy, according to WHAM. What could be accomplished with that funding?
Guests:
Dr. Pavitra Kotini-Shah, emergency room doctor, assistant Professor of Emergency Medicine and health disparities researcher at the University of Illinois at Chicago, and collaborative member of WHAM
Dr. Jan Werbinski, president of the American Medical Women's Association, clinical associate professor emeritus in the department of Obstetrics and Gynecology at Western Michigan University, founding president of the American College of Women’s Health Physicians, and executive director of the Sex and Gender Women’s Health Collaborative
Maya Dusenbery, journalist and author of Doing Harm: The Truth About How Bad Medicine and Lazy Science Leave Women Dismissed, Misdiagnosed, and Sick
Web Resources:
The Chicago Tribune: As the pandemic has shown, more needs to be done to factor sex, gender into biological research
NPR: How 'Bad Medicine' Dismisses And Misdiagnoses Women's Symptoms
Mother Jones: “You Need to Calm Down” and Other Degrading B.S. Women Hear from Doctors
The Hill: The NIH must address disparities in women’s health research funding
Katz Institute for Women's Health: The gender gap in health research funding is hurting all of us
CNBC: A subsection of tech is set to be worth $1 trillion. But taboos are holding it back
Nature: Women’s health research lacks funding – these charts show how
